Cover Image
市場調查報告書

脊椎炎:全球臨床實驗檢討

Spondylitis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 242622
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
脊椎炎:全球臨床實驗檢討 Spondylitis Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 60 Pages
簡介

本報告提供脊椎炎治療藥相關的臨床實驗資料,提供您臨床實驗數及受驗者人數,各階段及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等彙整資料。

簡介

  • 脊椎炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫症治療藥臨床實驗上脊椎炎所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:免疫症治療藥臨床實驗上脊椎炎所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

脊椎炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Schering-Plough Corporation (Inactive)
    • NuCel, LLC
    • Khorakiwala Holdings and Investments Private Limited
    • Hetero Drugs Limited
    • Bayer AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases
    • Central Council for Research in Homoeopathy
    • Turku University Hospital
    • Singapore General Hospital
    • Rehazentrum Bad Eilsen
    • Manipal University
    • University of Sao Paulo
    • Greenwich Hospital
    • Sun Yat-sen University
    • Assistance Publique - Hopitaux de Paris

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2409CTIDB

GlobalData's clinical trial report, "Spondylitis Global Clinical Trials Review, H2, 2014" provides data on the Spondylitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spondylitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spondylitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Spondylitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Spondylitis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Spondylitis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Spondylitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Spondylitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Schering-Plough Corporation (Inactive)
      • Clinical Trial Overview of Schering-Plough Corporation (Inactive)
      • NuCel, LLC
      • Clinical Trial Overview of NuCel, LLC
      • Khorakiwala Holdings and Investments Private Limited
      • Clinical Trial Overview of Khorakiwala Holdings and Investments Private Limited
      • Hetero Drugs Limited
      • Clinical Trial Overview of Hetero Drugs Limited
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Central Council for Research in Homoeopathy
      • Clinical Trial Overview of Central Council for Research in Homoeopathy
      • Turku University Hospital
      • Clinical Trial Overview of Turku University Hospital
      • Singapore General Hospital
      • Clinical Trial Overview of Singapore General Hospital
      • Rehazentrum Bad Eilsen
      • Clinical Trial Overview of Rehazentrum Bad Eilsen
      • Manipal University
      • Clinical Trial Overview of Manipal University
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • Greenwich Hospital
      • Clinical Trial Overview of Greenwich Hospital
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Spondylitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Spondylitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Spondylitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Spondylitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Spondylitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Spondylitis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Spondylitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spondylitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spondylitis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Spondylitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spondylitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spondylitis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spondylitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation (Inactive), 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by NuCel, LLC, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Khorakiwala Holdings and Investments Private Limited, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hetero Drugs Limited, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Council for Research in Homoeopathy, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Turku University Hospital, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rehazentrum Bad Eilsen, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Manipal University, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Greenwich Hospital, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014*
  • Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Spondylitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Spondylitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Spondylitis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Spondylitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spondylitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spondylitis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Spondylitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spondylitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Spondylitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spondylitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Spondylitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top